MA27949A1 - Pyrimidines 2-substituees. - Google Patents
Pyrimidines 2-substituees.Info
- Publication number
- MA27949A1 MA27949A1 MA28806A MA28806A MA27949A1 MA 27949 A1 MA27949 A1 MA 27949A1 MA 28806 A MA28806 A MA 28806A MA 28806 A MA28806 A MA 28806A MA 27949 A1 MA27949 A1 MA 27949A1
- Authority
- MA
- Morocco
- Prior art keywords
- substituted pyrimidines
- description
- pyrimidines
- substituted
- pesticides
- Prior art date
Links
- 150000003230 pyrimidines Chemical class 0.000 title 1
- -1 2-substituted pyrimidines Chemical class 0.000 abstract 2
- 239000000575 pesticide Substances 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10333857 | 2003-07-24 | ||
| DE10357714 | 2003-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27949A1 true MA27949A1 (fr) | 2006-06-01 |
Family
ID=34117367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28806A MA27949A1 (fr) | 2003-07-24 | 2006-02-15 | Pyrimidines 2-substituees. |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7375108B2 (https=) |
| EP (1) | EP1651618B1 (https=) |
| JP (1) | JP2006528603A (https=) |
| KR (1) | KR20060052857A (https=) |
| AP (1) | AP2157A (https=) |
| AR (1) | AR045100A1 (https=) |
| AT (1) | ATE350370T1 (https=) |
| AU (1) | AU2004261373B8 (https=) |
| BR (1) | BRPI0412891A (https=) |
| CA (1) | CA2532718A1 (https=) |
| CO (1) | CO5660292A2 (https=) |
| CR (1) | CR8184A (https=) |
| CY (1) | CY1106391T1 (https=) |
| DE (1) | DE502004002570D1 (https=) |
| DK (1) | DK1651618T3 (https=) |
| EA (1) | EA010566B1 (https=) |
| EC (1) | ECSP066278A (https=) |
| ES (1) | ES2279395T3 (https=) |
| HR (1) | HRP20070057T3 (https=) |
| IL (1) | IL172848A0 (https=) |
| MA (1) | MA27949A1 (https=) |
| MX (1) | MXPA06000038A (https=) |
| NZ (1) | NZ545103A (https=) |
| PE (1) | PE20050882A1 (https=) |
| PL (1) | PL1651618T3 (https=) |
| PT (1) | PT1651618E (https=) |
| SI (1) | SI1651618T1 (https=) |
| TW (1) | TW200516075A (https=) |
| UY (1) | UY28436A1 (https=) |
| WO (1) | WO2005012261A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1768972A1 (de) * | 2004-07-14 | 2007-04-04 | Basf Aktiengesellschaft | 2-substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen |
| CL2007002231A1 (es) * | 2006-08-02 | 2008-04-11 | Basf Ag | Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico. |
| BR112013011868A2 (pt) * | 2010-11-16 | 2016-08-23 | Acetylon Pharmaceuticals Inc | compostos de pirimidina hidróxi amida como inibidores da proteína desacetilase, composição farmacêutica e uso dos referidos compostos |
| ES2929576T3 (es) | 2013-10-08 | 2022-11-30 | Acetylon Pharmaceuticals Inc | Combinaciones de inhibidores de histona deacetilasa 6 y el inhibidor de Her2 lapatinib para el uso en el tratamiento del cáncer de mama |
| WO2015054474A1 (en) | 2013-10-10 | 2015-04-16 | Acetylon Pharmaceuticals, Inc. | Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors |
| US10660890B2 (en) | 2013-10-24 | 2020-05-26 | National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Nih Division Of Extramural Inventions And Technology Resources (Deitr) | Treatment of polycystic diseases with an HDAC6 inhibitor |
| CR20160308A (es) | 2013-12-03 | 2016-11-08 | Acetylon Pharmaceuticals Inc | Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores |
| US9464073B2 (en) | 2014-02-26 | 2016-10-11 | Acetylon Pharmaceuticals, Inc. | Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors |
| SG11201700094TA (en) | 2014-07-07 | 2017-02-27 | Acetylon Pharmaceuticals Inc | Treatment of leukemia with histone deacetylase inhibitors |
| US9937174B2 (en) | 2014-12-05 | 2018-04-10 | University of Modena and Reggio Emilia | Combinations of histone deacetylase inhibitors and bendamustine |
| US10272084B2 (en) | 2015-06-01 | 2019-04-30 | Regenacy Pharmaceuticals, Llc | Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy |
| EP3445364A4 (en) | 2016-04-19 | 2019-11-27 | Acetylon Pharmaceuticals, Inc. | HDAC INHIBITORS, ONLY OR IN COMBINATION WITH BTK INHIBITORS, FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| JP6976577B2 (ja) * | 2016-07-20 | 2021-12-08 | 国立大学法人東北大学 | ＰＰＡＲαアゴニストを含有する、肺高血圧症の予防又は治療剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE303367T1 (de) | 2000-06-13 | 2005-09-15 | 5 phenyl substituierte 2-(cyanoamino)-pyrimidine als fungizide | |
| WO2002074753A2 (de) | 2001-03-15 | 2002-09-26 | Basf Aktiengesellschaft | 5-phenylpyrimidine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von schadpilzen |
| CA2467683C (en) | 2001-11-19 | 2011-09-27 | Basf Aktiengesellschaft | 5-phenylpyrimidines, agents comprising the same, method for production and use thereof |
-
2004
- 2004-07-15 DK DK04741053T patent/DK1651618T3/da active
- 2004-07-15 CA CA002532718A patent/CA2532718A1/en not_active Abandoned
- 2004-07-15 PL PL04741053T patent/PL1651618T3/pl unknown
- 2004-07-15 EP EP04741053A patent/EP1651618B1/de not_active Expired - Lifetime
- 2004-07-15 BR BRPI0412891-5A patent/BRPI0412891A/pt not_active IP Right Cessation
- 2004-07-15 PT PT04741053T patent/PT1651618E/pt unknown
- 2004-07-15 MX MXPA06000038A patent/MXPA06000038A/es active IP Right Grant
- 2004-07-15 WO PCT/EP2004/007877 patent/WO2005012261A1/de not_active Ceased
- 2004-07-15 US US10/564,013 patent/US7375108B2/en not_active Expired - Fee Related
- 2004-07-15 AT AT04741053T patent/ATE350370T1/de not_active IP Right Cessation
- 2004-07-15 JP JP2006520743A patent/JP2006528603A/ja active Pending
- 2004-07-15 EA EA200600212A patent/EA010566B1/ru not_active IP Right Cessation
- 2004-07-15 AP AP2006003497A patent/AP2157A/xx active
- 2004-07-15 DE DE502004002570T patent/DE502004002570D1/de not_active Expired - Lifetime
- 2004-07-15 SI SI200430228T patent/SI1651618T1/sl unknown
- 2004-07-15 HR HR20070057T patent/HRP20070057T3/xx unknown
- 2004-07-15 NZ NZ545103A patent/NZ545103A/en unknown
- 2004-07-15 KR KR1020067001493A patent/KR20060052857A/ko not_active Ceased
- 2004-07-15 ES ES04741053T patent/ES2279395T3/es not_active Expired - Lifetime
- 2004-07-15 AU AU2004261373A patent/AU2004261373B8/en not_active Ceased
- 2004-07-22 PE PE2004000707A patent/PE20050882A1/es not_active Application Discontinuation
- 2004-07-23 UY UY28436A patent/UY28436A1/es unknown
- 2004-07-23 AR ARP040102631A patent/AR045100A1/es active IP Right Grant
- 2004-07-23 TW TW093122163A patent/TW200516075A/zh unknown
-
2005
- 2005-12-27 IL IL172848A patent/IL172848A0/en not_active IP Right Cessation
-
2006
- 2006-01-11 CR CR8184A patent/CR8184A/es unknown
- 2006-01-11 EC EC2006006278A patent/ECSP066278A/es unknown
- 2006-01-24 CO CO06006393A patent/CO5660292A2/es not_active Application Discontinuation
- 2006-02-15 MA MA28806A patent/MA27949A1/fr unknown
-
2007
- 2007-03-16 CY CY20071100372T patent/CY1106391T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA29411B1 (fr) | 1h-quinazoline -2,4-diones et leur utilisation en tant que ligands du recepteur ampa | |
| MA27949A1 (fr) | Pyrimidines 2-substituees. | |
| MA53219B1 (fr) | Nouveaux composés hétérocycliques en tant qu'inhibiteurs de monoacylglycérol lipase | |
| MA30911B1 (fr) | Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine | |
| TNSN02014A1 (fr) | Composes nouveaux agonistes de ppar et compositions les contenant | |
| MA29549B1 (fr) | Arylpyrazoles substitues destines a etre utilises contre des parasites | |
| MA31586B1 (fr) | Dérivés d'alcools alkyliques de 1-phényl-2-pyridinyle en tant qu'inhibiteurs de la phosphodiestérase | |
| TNSN00092A1 (fr) | Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA31597B1 (fr) | Nouveaux herbicides | |
| TNSN00191A1 (fr) | Composes nouveaux, compositions les contenant et leur utilisation dans le traitement d'une ischemie | |
| MA27668A1 (fr) | 2,4-di(phenylamino) pyrimidines utilisees pour traiter des maladies neoplasiques, des troubles inflammatoires et des troubles du systeme immunitaire | |
| TNSN02010A1 (fr) | Derives de pyrimidine nouveaux inhibiteurs de mmp, et compositions les contenant | |
| MA29652B1 (fr) | 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation | |
| MA31596B1 (fr) | Nouveaux herbicides | |
| TNSN99172A1 (fr) | 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN98045A1 (fr) | Derives de nicotinamide nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| TNSN02015A1 (fr) | Composes nouveaux antagonistes de ppar, et compositions les contenant | |
| MA43639B1 (fr) | Nouveaux dérivés d'ammonium, procédé de préparation de ceux-ci et compositions pharmaceutiques les contenant | |
| TNSN02011A1 (fr) | Derives de pyrimidine bicycliques nouveaux, inhibiteurs de mmp, et compositions les contenant | |
| TNSN00228A1 (fr) | Derives de benzimidazole nouveaux, et compositions les contenant | |
| MEP45308A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| MA32711B1 (fr) | Pyrrolidine-2-carboxamides substitues | |
| MA29377B1 (fr) | Derives de la pyrimidine pour traitement de troubles a caractere hyperproliferatif | |
| TNSN99155A1 (fr) | 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN97197A1 (fr) | Derives de pyrazole parasiticides, procede pour leur preparation et compositions les contenant. |